Positive clinical outcomes derived from using <em>Streptococcus salivarius</em> K12 to prevent streptococcal pharyngotonsillitis in children: a pilot investigation

Abstract

In agreement with previous findings, in the present study, it was found that the daily use of BLIS K12 has been associated with a concurrent and persisting reduction in the occurrence of pharyngeal, recurrent, streptococcal disease. Moreover, the benefits to children may also extend to a reduction of nonstreptococcal diseases, including tracheitis, viral pharyngitis, rhinitis, flu, laryngitis, acute otitis media, and enteritis.